Navamedic ASA acquires Impolin AB and bolsters its product portfolio
The proposed acquisition reinforces Navamedic's position in the market for obesity treatmentThe acquired portfolio enables Navamedic to support patients and consumers during weight loss or obesity
United Kingdom Kathrine Gamborg Andreassen Lars Hjarrand Prnewswire Navamedic Tony Brejke Oslo Stock Exchange
Source: finanznachrichten.de